Literature DB >> 7022723

Mast cell-dependent effector pathways and cutaneous bullous disorders.

B U Wintroub, M C Mihm.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7022723     DOI: 10.1007/bf01891886

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  26 in total

1.  An eosinophil chemotactic factor present in blister fluids of bullous pemphigoid patients.

Authors:  T Baba; H Sonozaki; K Seki; M Uchiyama; Y Ikesawa; M Toriisu
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

2.  DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING.

Authors:  E H BEUTNER; R E JORDON
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

3.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

4.  The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung.

Authors:  A B Kay; K F Austen
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

5.  Bullous pemphigoid antigen: isolation from normal human skin.

Authors:  L A Diaz; N J Calvanico; T B Tomasi; R E Jordon
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

6.  Ultrastructural localization of in vivo bound immunoglobulins in bullous pemphigoid--a preliminary report.

Authors:  G Schaumburg-Lever; A Rule; R Schmidt-Ullrich; W F Lever
Journal:  J Invest Dermatol       Date:  1975-01       Impact factor: 8.551

7.  Ultrastructural localization of in vivo-bound complement in bullous pemphigoid.

Authors:  B Schmidt-Ullrich; A Rule; G Schaumburg-Lever; C Leblanc
Journal:  J Invest Dermatol       Date:  1975-08       Impact factor: 8.551

8.  Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

Authors:  B U Wintroub; M C Mihm; E J Goetzl; N A Soter; K F Austen
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

9.  Basophilic leukocytes in allergic contact dermatitis.

Authors:  H F Dvorak; M C Mihm
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307

10.  The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.

Authors:  C G Cochrane; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1968-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.